About Breast Cancer Trials
Our Research
Research Results
Our People
Our Supporters
Financials
How You Can Help

About Breast Cancer Trials

Search

Recent Posts

Dr Sheridan Wilson
Associate Professor Nicholas Wilcken
Professor Andrew Spillane
Professor Christobel Saunders AO
Ms Marg O’Donnell AO

Recent Comments

No comments to show.

ABOUT BREAST CANCER TRIALS

Chair And CEO Report

Breast Cancer Today

OUR RESEARCH

What Is A Clinical Trial

The Year In Review

Director Of Research Report

2022-2026 Research Strategy

Our Clinical Trials

Participating Institutions & International Collaborators

2023 Clinical Fellowships & International Fellowship Support

Discretionary Funding

43rd Annual Scientific Meeting & Awards

RESEARCH RESULTS

Assessing the effect of breast cancer treatment on ovarian function

Blocking cell division helps with breast cancer relapse in older women

Breast MRI may allow some patients to safely avoid radiation therapy

New options for triple negative breast cancer patients

Olaparib increases survival for early breast cancer patients with BRCA1/2 gene mutations

Repurposing a common reflux drug to ease chemotherapy nausea

Suppressing ovarian function increases breast cancer survival in high-risk premenopausal women

Treatment simplified – no need to start hormonal therapy alongside chemotherapy

OUR PEOPLE

Board Of Directors

Consumer Advisory Panel

OUR SUPPORTERS

Individual Givers

Community Activists

Corporate & Foundation Partners

FINANCIALS

HOW YOU CAN HELP

Become a Member

Participate in a Clinical Trial

Your Support Can Save Lives

Contact Us • Disclaimer • Privacy Policy • Glossary

Copyright © 2023 ANZ Breast Cancer Trials Group Ltd | ABN 64 051 369 496